{"name":"Cathleen McCabe MD","slug":"cathleen-mccabe-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Durezol 0.05% Ophthalmic Emulsion","genericName":"Durezol 0.05% Ophthalmic Emulsion","slug":"durezol-0-05-ophthalmic-emulsion","indication":"Inflammation and pain following ocular surgery","status":"marketed"}]}],"pipeline":[{"name":"Durezol 0.05% Ophthalmic Emulsion","genericName":"Durezol 0.05% Ophthalmic Emulsion","slug":"durezol-0-05-ophthalmic-emulsion","phase":"marketed","mechanism":"Durezol (difluprednate) is a topical corticosteroid that suppresses inflammatory responses in the eye by inhibiting phospholipase A2 and reducing production of inflammatory mediators.","indications":["Inflammation and pain following ocular surgery","Endogenous anterior uveitis"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPOWpqZE90YUotTERGZHEyNHAtMkZvSjZpU1hoY0R6NV9TTnUzTG5iQ3lKU0FwMU9aQnR3eXZIbzJvMHJZRFNISTh3MFZOSi1RVjV3MnowQXR2Y2ZIRmFLVUlwU3VlNEhnRUpXYzhYMll0cWpJT01Kbk85X1Fpdnc0RXNsUHJpVmNFUnNhcTZ0bkpDRmpfdUZES1RSX0ZpamFqcVRuMkJHazA?oc=5","date":"2025-10-31","type":"pipeline","source":"Ophthalmology Times","summary":"AAO 2025: Ophthalmic World Leaders honors 2025 leadership awardees; names first MD president - Ophthalmology Times","headline":"AAO 2025: Ophthalmic World Leaders honors 2025 leadership awardees; names first MD president","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPUzZHcXhHOXJMQUlKTDdsSTlhWmRxak9lS3l3SE4yc0ZIa2JUX1dpR0NwVmdDcnVrZnMySWRwV0F4c2JTNS1tWDNKZ2g1cHpRWW5jQ2J5WFpLdkhrbnItMmFrZEhMQ241d2lzUUtjZHF6RXJ0VXB4N2ZkMkFQancweFNGTnlTQmFlaEdEM25kdXZZNUlETk1NU0FSMXhISHVralFaVFc1dw?oc=5","date":"2025-08-20","type":"pipeline","source":"Ophthalmology Times","summary":"The emerging era of presbyopia-correcting eye drops: What’s next? - Ophthalmology Times","headline":"The emerging era of presbyopia-correcting eye drops: What’s next?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE9Vbk5mbWRSWl9Ib2hseGU0elJpYm1xVmdUWXZWMVFBc2hxNHdYRFNsTkhSWkk5Wk5zR182OHVjZ29TdThKMjRwLUdKMVBWSlVaT192T2FIdDU5TWVfcnRXSXdsdWJlOVVBYnY0NFp2NA?oc=5","date":"2024-10-18","type":"pipeline","source":"EyeWorld","summary":"EyeWorld Onsite, October 18, 2024 - EyeWorld","headline":"EyeWorld Onsite, October 18, 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQMEI4by0yd05YME1sLXZqVGl4NE9kdlluYWNHQ1pwV21mQVhGNEwxc1VCSExTTTcxS2hLamVzVklFUXVTS1BjWkxHVHFQdjl0QUVXUmdoazZOUFhVdWFLUlhUWGFiZnNNdXRaSDVQS0tEVGI4VTAzZjJOOEFSMlhYdXJTZTdwM1RjcGJPaGkweWFnemhHeFB4OTFDLWNFTk9iVldF?oc=5","date":"2023-10-03","type":"pipeline","source":"Healio","summary":"VIDEO: Phentolamine drops rapidly reverse mydriasis - Healio","headline":"VIDEO: Phentolamine drops rapidly reverse mydriasis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE1qZFRrV2VXSmFEdTdBQ21adUNqTko4Y0xzRkh4aVRrSEVTMkZWeEFWR2JpV1NhM01jOEk5alBXUDFnSXcyTTNNdkdlUWszZzZMMnlZT2cza2NUV3VESWF4RDFuY2lPYzE3X3djbHBoS0tvS0ZzNGxv?oc=5","date":"2023-07-21","type":"pipeline","source":"EyeWorld","summary":"Lindstrom Lecture and symposium recap - EyeWorld","headline":"Lindstrom Lecture and symposium recap","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQWHlSUkkzajlCM0ktaXphRGJZazVRTGpJN25tRDcxSkRieFZqMmxFNU5mZWpBX2RrLUxLdGFOcEdvQ0tKU0VCeVVueHAzeHlpRnYtakdVZGdDZkR1UkZ1aDJZRXFMTElfMGZPa0ZnMjFwdmtsUmVzNXdYQTlkMjRFZVZDcWlsdk9wek9CMlpGN2JBRlNYemhad1BZbVpyUDQ3Q1EwS0FwRi15S01lN2Q4U3lvWF8xRmR5ZU1sZk9hQmxycms?oc=5","date":"2022-12-01","type":"pipeline","source":"Healio","summary":"Belt loop technique another option for scleral fixation of bag/lens complex - Healio","headline":"Belt loop technique another option for scleral fixation of bag/lens complex","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxOSXRoaVc0RTY5NmwyZDlueFdrOGNOcnFIbk1JaTRtT0JFWkg3ZkgtbTVDZ1pZTlNJWnN2OU5EMWxLQ1FnZzJWR21SLXFhaWd0cDAzZVdPNnoydERVUm1BcklRaHdmSFVaMkdUS3p5el9UeHpLdDhHOHh1WVQxeTR6YnhjVmFRa2w4VC1lQ1hsUVhObS1QUzRqdkZEanpHUEdoeTZNa2hxNmRJUjNLanpySktBSVAxMGx5RzNJUEZ2Z1g2ZktrMDJ2dmJiRkU?oc=5","date":"2022-06-20","type":"pipeline","source":"dovepress.com","summary":"OPTH - dovepress.com","headline":"OPTH","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxNUDZITU1VaTFMcUIwZVA1cGUyOGtCQ2Y2Ykc4a1RidVd5T3N0Q0xVOUtybVAyUV9iNFFfS1NUVDZmV05mQXB4T0wyZlNXU1dfQWhRV1RPRGs3MDhrVDJDSF9IbjVHVUExSmdCQ2wxeXRQbEJOYjJVcVMwekFwVnhYVlJwR0NJVDVjT1h2MzdLWW8wcFE2UzJvbjVGZm0xSzQyNEktWm5RcnlZbjkzRktnTExZN2FwVFZDRDFIQ1N3R0dUYTBSdVN4LXBITy1Sempm?oc=5","date":"2022-05-21","type":"pipeline","source":"EyeWorld","summary":"Multisociety OICS Task Force issues recommendations on reducing topical drug waste in ophthalmic surgery - EyeWorld","headline":"Multisociety OICS Task Force issues recommendations on reducing topical drug waste in ophthalmic surgery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQY2ZnWjRndkw0eUdWVGJBVnNqcDdfTFd3RDVoazZ0aFhIMUJtUmlaSFZRQmlSUUp2NGllTm9DOFJpeHVYVF9xMkVSZ1NWOF9ZdHZISlQ5aUU1bWR0MF9yNEFWblN2VThsb2RqNmhFVHczTXhvMzQtLXRadzM4MmlEZW9ha1hHWDFpN2ZvZnVTTEp1cHpKbTJIM1dIQzJPWDI0ZTgyT1gyUFpwVUpmWGFCb05MLWdCN2lGRVo3LXFZZFNvUQ?oc=5","date":"2021-07-23","type":"trial","source":"Ophthalmology Times","summary":"Study: Dexamethasone intraocular suspension 9% offering high surgeon, patient satisfaction after cataract surgery - Ophthalmology Times","headline":"Study: Dexamethasone intraocular suspension 9% offering high surgeon, patient satisfaction after cataract surgery","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQMHN5Vl9aRkpBLWVKUlUzYldvUmRqQmtwVEI2TVFBUTl1UG9ZUHYtcC1kUXBMdnI3MGhySDVuVTZDenE3WjE3SUpBcUZLM3pZUnZlQWxWNGRMMm91NU5Qa0ZVVFdmWDBUWTc4X09iWkl5OFZqQzJIUVZmdDNrY0Z6QWo2Q2dub2hZWUNBajNlTQ?oc=5","date":"2020-07-01","type":"pipeline","source":"Ophthalmology Times","summary":"Surgeons discuss MIPS, impact of pass-through medications - Ophthalmology Times","headline":"Surgeons discuss MIPS, impact of pass-through medications","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}